EMV Capital: AMR Bio targets FDA meeting to clear path for XF-73 Phase 3 trial
Proactive - Interviews for investors · Proactive Investors
July 31, 20269m 25s
Audio is streamed directly from the publisher (cdn.simplecast.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.